149 related articles for article (PubMed ID: 26367749)
1. Epidermodysplasia verruciformis: successful treatment with squaric acid dibutylester.
Kehdy J; Erickson C; Rady P; Tyring S; Gaspari AA
Cutis; 2015 Aug; 96(2):114-8. PubMed ID: 26367749
[TBL] [Abstract][Full Text] [Related]
2. Patients with epidermodysplasia verruciformis show no response to contact immunotherapy.
Ishiji T; Ibe M; Kawase M; Niimura M
Dermatology; 2001; 202(1):76-7. PubMed ID: 11244240
[No Abstract] [Full Text] [Related]
3. Adult and paediatric contact immunotherapy with squaric acid dibutylester (SADBE) for recurrent, multiple, resistant, mucocutaneous anogenital warts.
Dall' Oglio F; Nasca MR; D'Agata O; Micali G
Sex Transm Infect; 2002 Aug; 78(4):309-10. PubMed ID: 12181482
[No Abstract] [Full Text] [Related]
4. Change in cytokines in patients with warts after contact immunotherapy with squaric acid dibutylester.
Park HJ; Choi YW; Kim SH; Shin MS; Lee SW; Oh MK; Choi HY
Clin Exp Dermatol; 2013 Oct; 38(7):775-81. PubMed ID: 23611147
[TBL] [Abstract][Full Text] [Related]
5. Use of squaric acid dibutylester (SADBE) for cutaneous warts in children.
Micali G; Nasca MR; Tedeschi A; Dall'Oglio F; Pulvirenti N
Pediatr Dermatol; 2000; 17(4):315-8. PubMed ID: 10990585
[TBL] [Abstract][Full Text] [Related]
6. Squaric acid immunotherapy for warts in children.
Silverberg NB; Lim JK; Paller AS; Mancini AJ
J Am Acad Dermatol; 2000 May; 42(5 Pt 1):803-8. PubMed ID: 10775858
[TBL] [Abstract][Full Text] [Related]
7. Contact immunotherapy with squaric acid dibutylester for the treatment of recalcitrant warts.
Lee AN; Mallory SB
J Am Acad Dermatol; 1999 Oct; 41(4):595-9. PubMed ID: 10495383
[TBL] [Abstract][Full Text] [Related]
8. Discoid lupus erythematosus exacerbated by contact dermatitis caused by use of squaric acid dibutylester for topical immunotherapy in a patient with alopecia areata.
Shimaoka Y; Hatamochi A; Hamasaki Y; Suzuki H; Ikeda H; Yamazaki S
J Dermatol; 2008 Mar; 35(3):151-3. PubMed ID: 18346258
[TBL] [Abstract][Full Text] [Related]
9. Treatment of Multiple-Resistant and/or Recurrent Cutaneous Warts With Squaric Acid Dibutylester: A Randomized, Double-blind, Vehicle-controlled Clinical Trial.
DallʼOglio F; Luca M; Barresi S; Micali G
Dermatitis; 2017; 28(5):308-312. PubMed ID: 28885314
[TBL] [Abstract][Full Text] [Related]
10. Acquired epidermodysplasia verruciformis in a child with atopic dermatitis.
Fernandez KH; Rady P; Tyring S; Stone MS
Pediatr Dermatol; 2014; 31(3):400-2. PubMed ID: 22938530
[TBL] [Abstract][Full Text] [Related]
11. [Immunotherapy of multiple recurring warts. II. Reassessment of the use of squaric acid dibutylester (SADBE) (author's transl)].
Claudy AL; Roche H
Ann Dermatol Venereol; 1981; 108(10):765-7. PubMed ID: 7305218
[TBL] [Abstract][Full Text] [Related]
12. Treatment of alopecia areata with squaric acid dibutylester.
Hill ND; Bunata K; Hebert AA
Clin Dermatol; 2015; 33(3):300-4. PubMed ID: 25889130
[TBL] [Abstract][Full Text] [Related]
13. Treatment of cutaneous warts with squaric acid dibutylester: a decade of experience.
Micali G; Dall'Oglio F; Tedeschi A; Pulvirenti N; Nasca MR
Arch Dermatol; 2000 Apr; 136(4):557-8. PubMed ID: 10768664
[No Abstract] [Full Text] [Related]
14. Treatment of warts with contact allergens.
Word AP; Nezafati KA; Cruz PD
Dermatitis; 2015; 26(1):32-7. PubMed ID: 25581668
[TBL] [Abstract][Full Text] [Related]
15. Acquired epidermodysplasia verruciformis in an HIV-positive patient.
Lau C; Acharya S; Arumainayagam JT; Kasparis C; Dhesi I
Int J STD AIDS; 2016 Oct; 27(11):1023-5. PubMed ID: 26516132
[TBL] [Abstract][Full Text] [Related]
16. Contact immunotherapy with squaric acid dibutylester for warts [corrected].
Iijima S; Otsuka F
Dermatology; 1993; 187(2):115-8. PubMed ID: 8358098
[TBL] [Abstract][Full Text] [Related]
17. Usefulness of topical immunotherapy with squaric acid dibutylester for refractory common warts on the face and neck.
Hama N; Hatamochi A; Hayashi S; Namikawa H; Sotome A; Hamasaki Y; Yamazaki S
J Dermatol; 2009 Dec; 36(12):660-2. PubMed ID: 19958453
[No Abstract] [Full Text] [Related]
18. Seventeen cases of alopecia areata: combination of SADBE topical immunotherapy with other therapies.
Morita K; Nakamura M; Nagamachi M; Kishi T; Miyachi Y
J Dermatol; 2002 Oct; 29(10):661-4. PubMed ID: 12433000
[TBL] [Abstract][Full Text] [Related]
19. Examining the efficacy and safety of squaric acid therapy for treatment of recalcitrant warts in children.
Pandey S; Wilmer EN; Morrell DS
Pediatr Dermatol; 2015; 32(1):85-90. PubMed ID: 25040421
[TBL] [Abstract][Full Text] [Related]
20. Angioedema After Squaric Acid Treatment in a 6-Year-Old Girl.
Chen CA; Carlberg V; Kroshinsky D
Pediatr Dermatol; 2017 Jan; 34(1):e44-e46. PubMed ID: 27699860
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
